|Hydrolysis of capecitabine to 5′-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide|
SK Quinney, SP Sanghani, WI Davis, TD Hurley, Z Sun, DJ Murry, ...
Journal of Pharmacology and Experimental Therapeutics 313 (3), 1011-1016, 2005
|Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia|
A Egbelakin, MJ Ferguson, EA MacGill, AS Lehmann, AR Topletz, ...
Pediatric blood & cancer 56 (3), 361-367, 2011
|Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis|
SP Sanghani, SK Quinney, TB Fredenburg, Z Sun, WI Davis, DJ Murry, ...
Clinical Cancer Research 9 (13), 4983-4991, 2003
|Hydrolysis of irinotecan and its oxidative metabolites, 7-ethyl-10-[4-N-(5-aminopentanoic acid)-1-piperidino] carbonyloxycamptothecin and 7-ethyl-10-[4-(1-piperidino)-1-amino …|
SP Sanghani, SK Quinney, TB Fredenburg, WI Davis, DJ Murry, ...
Drug Metabolism and Disposition 32 (5), 505-511, 2004
|Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions|
JD Duke, X Han, Z Wang, A Subhadarshini, SD Karnik, X Li, SD Hall, ...
PLoS computational biology 8 (8), e1002614, 2012
|Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite|
X Zhang, SK Quinney, JC Gorski, DR Jones, SD Hall
Drug Metabolism and Disposition 37 (8), 1587-1597, 2009
|Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin|
SK Quinney, X Zhang, A Lucksiri, JC Gorski, L Li, SD Hall
Drug metabolism and disposition 38 (2), 241-248, 2010
|Association of genotypes of the CYP3A cluster with midazolam disposition in vivo|
J Miao, Y Jin, RL Marunde, S Kim, S Quinney, M Radovich, L Li, SD Hall
The pharmacogenomics journal 9 (5), 319, 2009
|Predicting the glomerular filtration rate in bariatric surgery patients|
AN Friedman, S Moe, WF Fadel, M Inman, SG Mattar, Z Shihabi, ...
American journal of nephrology 39 (1), 8-15, 2014
|Interaction between midazolam and clarithromycin in the elderly|
SK Quinney, BD Haehner, MB Rhoades, Z Lin, JC Gorski, SD Hall
British journal of clinical pharmacology 65 (1), 98-109, 2008
|An integrated pharmacokinetics ontology and corpus for text mining|
HY Wu, S Karnik, A Subhadarshini, Z Wang, S Philips, X Han, C Chiang, ...
BMC bioinformatics 14 (1), 35, 2013
|Measuring the glomerular filtration rate in obese individuals without overt kidney disease|
AN Friedman, M Strother, SK Quinney, S Hall, SM Perkins, EJ Brizendine, ...
Nephron Clinical Practice 116 (3), c224-c234, 2010
|Short-term tocolytics for preterm delivery–current perspectives|
DM Haas, T Benjamin, R Sawyer, SK Quinney
International journal of women's health 6, 343, 2014
|Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic|
DM Haas, SK Quinney, JM Clay, JL Renbarger, MF Hebert, S Clark, ...
American journal of perinatology 30 (04), 275-282, 2013
|Hydroxyitraconazole, formed during intestinal first-pass metabolism of itraconazole, controls the time course of hepatic CYP3A inhibition and the bioavailability of …|
SK Quinney, RE Galinsky, VA Jiyamapa-Serna, Y Chen, MA Hamman, ...
Drug Metabolism and disposition 36 (6), 1097-1101, 2008
|Literature mining on pharmacokinetics numerical data: a feasibility study|
Z Wang, S Kim, SK Quinney, Y Guo, SD Hall, LM Rocha, L Li
Journal of biomedical informatics 42 (4), 726-735, 2009
|Gestational diabetes induces alterations in the function of neonatal endothelial colony-forming cells|
EK Blue, R DiGiuseppe, E Derr-Yellin, JC Acosta, SL Pay, H Hanenberg, ...
Pediatric research 75 (2), 266, 2014
|Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in rats|
X Zhang, RE Galinsky, RE Kimura, SK Quinney, DR Jones, SD Hall
Drug Metabolism and Disposition 38 (1), 61-72, 2010
|CYP2B6 Pharmacogenetics–Based In Vitro–In Vivo Extrapolation of Efavirenz Clearance by Physiologically Based Pharmacokinetic Modeling|
C Xu, SK Quinney, Y Guo, SD Hall, L Li, Z Desta
Drug Metabolism and Disposition 41 (12), 2004-2011, 2013
|Pharmacoepidemiologic and in vitro evaluation of potential drug–drug interactions of sulfonylureas with fibrates and statins|
H Schelleman, X Han, CM Brensinger, SK Quinney, WB Bilker, ...
British journal of clinical pharmacology 78 (3), 639-648, 2014